Patricia W. H. Hugen

Low Plasma Concentrations of Indinavir are Related to Virological Treatment Failure in HIV-1-Infected Patients on Indinavir-Containing Triple Therapy

David M. Burger, Richard M. W. Hoetelmans, Patricia W. H. Hugen et al. · Antiviral Therapy · 1998 · 161 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals

David M. Burger, Patricia W. H. Hugen, Peter Reiss et al. · AIDS · 2003 · 147 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Assessment of Adherence to HIV Protease Inhibitors: Comparison and Combination of Various Methods, Including MEMS (Electronic Monitoring), Patient and Nurse Report, and Therapeutic Drug Monitoring

Patricia W. H. Hugen, Nienke Langebeek, David M. Burger et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2002 · 127 citations

Pharmacy, Clinical Pharmacy, Infectious Diseases +17

Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography

Patricia W. H. Hugen, C.P.W.G.M. Verwey-van Wissen, David M. Burger et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1999 · 107 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Carbamazepine–Indinavir Interaction Causes Antiretroviral Therapy Failure

Patricia W. H. Hugen, David M. Burger, Kees Brinkman et al. · Annals of Pharmacotherapy · 2000 · 85 citations

Medicine, Pharmacology, Pharmacotherapy +17